<item>
  <date>2020-12-12</date>
  <hash>0a431bf7c60a2b6a7bdc62036ef2a793f096a400</hash>
  <image>https://cna-sg-res.cloudinary.com/image/upload/q_auto,f_auto/image/13757114/16x9/991/557/f14aa68ea6f7366985bdc5e5c59d7d97/NH/peru-s-clinical-trials-for-the-vaccine-developed-by-chinese-drug-giant-sinopharm-were-due-to-conclude-this-week-after-testing-around-12000-people-1607755322370-2.jpg</image>
  <images>
    <723759f8c79733038dbc5edf7b1ba64bc54903f4>https://cna-sg-res.cloudinary.com/image/upload/q_auto,f_auto/image/13757114/16x9/991/557/f14aa68ea6f7366985bdc5e5c59d7d97/NH/peru-s-clinical-trials-for-the-vaccine-developed-by-chinese-drug-giant-sinopharm-were-due-to-conclude-this-week-after-testing-around-12000-people-1607755322370-2.jpg</723759f8c79733038dbc5edf7b1ba64bc54903f4>
  </images>
  <index>27</index>
  <keywords>
    <name>COVID-19 pandemic</name>
    <index>1</index>
    <slug>/wiki/covid-19%20pandemic</slug>
  </keywords>
  <keywords>
    <name>Peru</name>
    <index>2</index>
    <slug>/wiki/peru</slug>
  </keywords>
  <keywords>
    <name>Phase III</name>
    <index>14</index>
    <slug>/wiki/phases%20of%20clinical%20research#phase_iii</slug>
  </keywords>
  <keywords>
    <name>Sinopharm</name>
    <index>37</index>
    <slug>/wiki/sinopharm</slug>
  </keywords>
  <keywords_list>COVID-19 pandemic</keywords_list>
  <keywords_list>Peru</keywords_list>
  <keywords_list>Phase III</keywords_list>
  <keywords_list>Sinopharm</keywords_list>
  <keywords_main>COVID-19 pandemic</keywords_main>
  <related>
    <date>2021-08-24</date>
    <hash>c165b48ca7995df5588e173ae00b4db6ff94513a</hash>
    <index>41</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Sinopharm</keywords>
    <score>2</score>
    <slug>/feed/2021/08/24/the-national-agency-for-food-and-drug-administration-and-control-approves-the-sinopharm-bbibp-corv-vaccine-for-emergency</slug>
    <text>The National Agency for Food and Drug Administration and Control approves the Sinopharm BBIBP-CorV vaccine for emergency use in Nigeria. </text>
  </related>
  <related>
    <changes>
      <date>2021-08-12</date>
      <hash>b143bd033949a2a0790db333d6ebe7f214f34f07</hash>
      <slug>/feed/2021/08/12/cambodia-begins-to-offer-the-oxford-astrazeneca-covid-19-vaccine-as-a-third-booster-dose-to-those-who-have-received-th</slug>
      <text>Cambodia begins to offer the Oxford-AstraZeneca COVID-19 vaccine as a third &quot;booster&quot; dose to those who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (Coronavac) in order to bolstering immunity against the SARS-CoV-2 Delta variant. </text>
      <timestamp>1628802558</timestamp>
    </changes>
    <date>2021-08-12</date>
    <hash>4426bd7f07862e7b2f5a297868fdd59efb7aaf14</hash>
    <index>29</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Sinopharm</keywords>
    <score>2</score>
    <slug>/feed/2021/08/12/cambodia-begins-to-administer-the-oxford-astrazeneca-covid-19-vaccine-as-a-third-booster-dose-to-people-who-have-recei</slug>
    <text>Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third &quot;booster&quot; dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant. </text>
  </related>
  <related>
    <changes>
      <date>2021-06-4</date>
      <hash>69123f3f6a65b8d8ca485e289270ade93088044c</hash>
      <slug>/feed/2021/06/4/the-ministry-of-health-approves-the-emergency-use-of-the-sinopharm-s-bbibp-corv-vaccine-making-it-the-third-vaccine-to</slug>
      <text>The Ministry of Health approves the emergency use of the Sinopharm's BBIBP-CorV vaccine, making it the third vaccine to be authorized in the country. </text>
      <timestamp>1622852764</timestamp>
    </changes>
    <date>2021-06-4</date>
    <hash>9d4919485a8b639e0c10b418018fe00b8dbe8c34</hash>
    <index>13</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Sinopharm</keywords>
    <score>2</score>
    <slug>/feed/2021/06/4/the-ministry-of-health-approves-the-emergency-use-of-the-sinopharm-bbibp-corv-vaccine-making-it-the-third-vaccine-to-be</slug>
    <text>The Ministry of Health approves the emergency use of the Sinopharm BBIBP-CorV vaccine, making it the third vaccine to be authorized for use in the country. </text>
  </related>
  <related>
    <changes>
      <date>2021-03-25</date>
      <hash>3ad28c81ba0b0601eb70b36d60db258964c2d496</hash>
      <slug>/feed/2021/03/25/ukraine-reports-a-record-16669-new-confirmed-cases-and-362-deaths-in-the-past-24-hours-thereby-bringing-the-nationwide</slug>
      <text>Ukraine reports a record 16,669 new confirmed cases and 362 deaths in the past 24 hours, thereby bringing the nationwide total of confirmed cases to 1,596,575 and the nationwide death toll to 31,135. </text>
      <timestamp>1764238194</timestamp>
    </changes>
    <changes>
      <date>2021-03-25</date>
      <hash>e8b1ce4f5ca1f2b7d41a947bf9e9c9795896520e</hash>
      <slug>/feed/2021/03/25/hungary-reports-a-record-272-deaths-from-covid-19-in-the-past-24-hours-thereby-bringing-the-nationwide-death-toll-to-19</slug>
      <text>Hungary reports a record 272 deaths from COVID-19 in the past 24 hours, thereby bringing the nationwide death toll to 19,224. </text>
      <timestamp>1764238192</timestamp>
    </changes>
    <changes>
      <date>2021-03-25</date>
      <hash>6ac1c12ecd153f7c9f2538204596c06b374896af</hash>
      <slug>/feed/2021/03/25/the-philippines-reports-a-record-8773-new-confirmed-cases-of-covid-19-in-the-past-24-hours-thereby-bringing-the-nation</slug>
      <text>The Philippines reports a record 8,773 new confirmed cases of COVID-19 in the past 24 hours, thereby bringing the nationwide total of confirmed cases to 693,048. </text>
      <timestamp>1764238183</timestamp>
    </changes>
    <changes>
      <date>2021-03-25</date>
      <hash>100532f6b1c977f45c07b9815ebb73616e2ef50b</hash>
      <slug>/feed/2021/03/25/brazil-reports-a-record-100158-new-confirmed-cases-of-covid-19-in-the-past-24-hours</slug>
      <text>Brazil reports a record 100,158 new confirmed cases of COVID-19 in the past 24 hours. </text>
      <timestamp>1763373532</timestamp>
    </changes>
    <changes>
      <date>2021-03-25</date>
      <hash>41391adc7a4fa895375285ef4e97d8b7024c448e</hash>
      <slug>/feed/2021/03/25/hungary-reports-a-record-272-new-fatalities-of-covid-19-in-the-past-24-hours-thus-bringing-the-nationwide-death-toll-to</slug>
      <text>Hungary reports a record 272 new fatalities of COVID-19 in the past 24 hours, thus bringing the nationwide death toll to 19,224. </text>
      <timestamp>1616720759</timestamp>
    </changes>
    <changes>
      <date>2021-03-25</date>
      <hash>e6afd121b99ab94638f8ec2c63ce426eeade4586</hash>
      <slug>/feed/2021/03/25/ukraine-reports-a-record-16669-new-confirmed-cases-and-362-deaths-of-covid-19-in-the-past-24-hours-thus-bringing-the-n</slug>
      <text>Ukraine reports a record 16,669 new confirmed cases and 362 deaths of COVID-19 in the past 24 hours, thus bringing the nationwide total of confirmed cases to 1,596,575 and the nationwide death toll to 31,135. </text>
      <timestamp>1616720758</timestamp>
    </changes>
    <changes>
      <date>2021-03-25</date>
      <hash>6676a0a1617db06d866fb5d80dd42008ca20bd0f</hash>
      <slug>/feed/2021/03/25/peru-reports-a-record-11260-new-confirmed-cases-of-covid-19-in-the-past-24-hours-amid-the-spread-of-the-lineage-p1-var</slug>
      <text>Peru reports a record 11,260 new confirmed cases of COVID-19 in the past 24 hours amid the spread of the Lineage P.1 variant, thereby bringing the nationwide total of confirmed cases to 1,492,519. </text>
      <timestamp>1616720755</timestamp>
    </changes>
    <date>2021-03-25</date>
    <hash>b1233da3a8d518034e0a10fb3853c078996864ba</hash>
    <index>40</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Peru</keywords>
    <score>2</score>
    <slug>/feed/2021/03/25/peru-reports-a-record-11260-new-confirmed-cases-of-covid-19-in-the-past-24-hours-thereby-bringing-the-nationwide-total</slug>
    <text>Peru reports a record 11,260 new confirmed cases of COVID-19 in the past 24 hours, thereby bringing the nationwide total of confirmed cases to 1,492,519. </text>
  </related>
  <related>
    <changes>
      <date>2021-03-2</date>
      <hash>dad00d77b7e3ed64b8aed784b3d08a42b44b7898</hash>
      <slug>/feed/2021/03/2/venezuela-receives-500000-doses-of-sinopharm-bbibp-corv-vaccine-donated-by-china-along-with-protective-material-for-he</slug>
      <text>Venezuela receives 500,000 doses of Sinopharm BBIBP-CorV vaccine donated by China, along with protective material for health workers. </text>
      <timestamp>1614740760</timestamp>
    </changes>
    <date>2021-03-2</date>
    <hash>a1d6d348ab9d030bf8303f7491f4e6eb40d0ccbc</hash>
    <index>70</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Sinopharm</keywords>
    <score>2</score>
    <slug>/feed/2021/03/2/venezuela-receives-500000-doses-of-the-sinopharm-bbibp-corv-vaccine-donated-by-china</slug>
    <text>Venezuela receives 500,000 doses of the Sinopharm BBIBP-CorV vaccine donated by China. </text>
  </related>
  <related>
    <changes>
      <date>2021-03-1</date>
      <hash>6bf786faae413c1213b02ca2fdf4f78e34469a2e</hash>
      <slug>/feed/2021/03/1/jordan-approves-the-emergency-use-of-single-dose-johnson-johnson-vaccine</slug>
      <text>Jordan approves the emergency use of single-dose Johnson &amp; Johnson vaccine. </text>
      <timestamp>1614647168</timestamp>
    </changes>
    <date>2021-03-1</date>
    <hash>af1560f5392c2927866bf8816cff86ff9c9bd498</hash>
    <index>43</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Sinopharm</keywords>
    <score>2</score>
    <slug>/feed/2021/03/1/venezuela-approves-the-emergency-use-of-sinopharm-bbibp-corv-vaccine</slug>
    <text>Venezuela approves the emergency use of Sinopharm BBIBP-CorV vaccine. </text>
  </related>
  <related>
    <changes>
      <date>2021-02-10</date>
      <hash>24b4a7aea87d451f71f035a45131eb918ef5faab</hash>
      <slug>/feed/2021/02/10/cambodia-launches-a-vaccination-campaign-against-covid-19-using-600000-doses-of-sinopharm-vaccine-the-son-of-prime-min</slug>
      <text>Cambodia launches a vaccination campaign against COVID-19 using 600,000 doses of Sinopharm vaccine. The son of Prime Minister Hun Sen, Hun Manet, and several cabinet ministers are the first people to get vaccinated. </text>
      <timestamp>1612962372</timestamp>
    </changes>
    <date>2021-02-10</date>
    <hash>281a99fd6f6a425e389e91325e9d16cb07fe5e1e</hash>
    <index>26</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Sinopharm</keywords>
    <score>2</score>
    <slug>/feed/2021/02/10/cambodia-launches-a-vaccination-campaign-against-covid-19-using-600000-doses-of-sinopharm-s-bbibp-corv-vaccine-the-son</slug>
    <text>Cambodia launches a vaccination campaign against COVID-19 using 600,000 doses of Sinopharm's BBIBP-CorV vaccine. The son of Prime Minister Hun Sen, Hun Manet, and several cabinet ministers are among the first people to get vaccinated. </text>
  </related>
  <related>
    <changes>
      <date>2021-02-9</date>
      <hash>ca6423e57ea57434f48ef8bde878747df3a3c847</hash>
      <slug>/feed/2021/02/9/peru-launches-a-vaccination-program-against-covid-19-two-days-after-it-received-300000-doses-of-bbibp-corv-from-sinopha</slug>
      <text>Peru launches a vaccination program against COVID-19 two days after it received 300,000 doses of BBIBP-CorV from Sinopharm. President Francisco Sagasti becomes the first person to get vaccinated. </text>
      <timestamp>1612933512</timestamp>
    </changes>
    <date>2021-02-9</date>
    <hash>c483705a6b90b3734b8a7ce0b4a1fe24fee8d1d1</hash>
    <index>42</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Peru</keywords>
    <keywords>Sinopharm</keywords>
    <score>3</score>
    <slug>/feed/2021/02/9/peru-launches-a-vaccination-program-against-covid-19-two-days-after-it-received-300000-doses-of-sinopharm-s-bbibp-corv</slug>
    <text>Peru launches a vaccination program against COVID-19 two days after it received 300,000 doses of Sinopharm's BBIBP-CorV vaccine. President Francisco Sagasti becomes the first person to get vaccinated. </text>
  </related>
  <related>
    <changes>
      <date>2020-10-20</date>
      <hash>081003ed283fb9c2eb7f3700216a07a73ece56f7</hash>
      <slug>/feed/2020/10/20/sinopharm-is-setting-up-production-lines-to-supply-up-to-1-billion-doses-of-two-covid-19-vaccines-currently-being-tested</slug>
      <text>Sinopharm is setting up production lines to supply up to 1 billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials. Sinopharm is currently testing the vaccines in 10 countries including Egypt, Argentina, Jordan, and Peru. </text>
      <timestamp>1603236847</timestamp>
    </changes>
    <date>2020-10-20</date>
    <hash>a295eb9e69ce99981d6080cdb890a686caf70506</hash>
    <index>22</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Peru</keywords>
    <keywords>Sinopharm</keywords>
    <score>3</score>
    <slug>/feed/2020/10/20/sinopharm-is-setting-up-production-lines-to-supply-up-to-one-billion-doses-of-two-covid-19-vaccines-currently-being-test</slug>
    <text>Sinopharm is setting up production lines to supply up to one billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials. Sinopharm is currently testing the vaccines in ten countries, including Egypt, Argentina, Jordan, and Peru. </text>
  </related>
  <related>
    <date>2020-09-10</date>
    <hash>ef63fe3300fa54478bb7b9bbcd7641a51e789ca8</hash>
    <index>27</index>
    <keywords>COVID-19 pandemic</keywords>
    <keywords>Peru</keywords>
    <keywords>Sinopharm</keywords>
    <score>3</score>
    <slug>/feed/2020/09/10/sinopharm-began-phase-iii-trials-in-peru-starting-with-two-dozen-people-with-the-goal-to-vaccinate-6000-people-between</slug>
    <text>Sinopharm began Phase III trials in Peru starting with two dozen people, with the goal to vaccinate 6,000 people between the ages of 18 and 75. So far, Sinopharm has given 30,000 doses to volunteers and another 10,000 participants have received double doses in Bahrain and the United Arab Emirates, with additional trials planned for Morocco and Argentina. </text>
  </related>
  <slug>/feed/2020/12/12/peru-temporarily-suspends-phase-iii-trials-of-sinopharm-s-vaccine-after-detecting-neurological-problems-in-one-of-its-vo</slug>
  <sources>
    <name>CNA</name>
    <day>12</day>
    <hash>723759f8c79733038dbc5edf7b1ba64bc54903f4</hash>
    <month>12</month>
    <permalink>https://www.channelnewsasia.com/news/world/peru-suspends-clinical-trials-china-sinopharm-covid-19-vaccine-13757116</permalink>
    <title>Peru suspends clinical trials of Chinese COVID-19 vaccine</title>
    <year>2020</year>
  </sources>
  <subtext>Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in ...</subtext>
  <text>Peru temporarily suspends Phase III trials of Sinopharm's vaccine after detecting neurological problems in one of its volunteers. Peru's trials for the vaccine were due to conclude this week, after testing around 12,000 people. </text>
</item>
